Professor, Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School
Cardiology
Dr. Charles M. Gibson, MD
|
|
Give Review
Charles Gibson practices Cardiology. He went to medical school at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. He has 3 awards "America's Top Doctors", "Boston Magazine" and "Fellow (FACC)". Doctor Charles M. Gibson, MD is also a published doctor. He has 44 publication published. The most recent publication is: EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary pe... Charles M. Gibson, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing Primary pe...
- Bioresorbable vascular scaffolds in daily clinical practice: is the essential really invisible to the eyes?
- Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in Acute ST-segment elevation myocardial infarction.
- Sex, adverse cardiac events, and infarct size in anterior myocardial infarction: an analysis of intraCoronary abciximab and aspiration thrombectomy in patients with la...
- Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic Cardiomyopathy.
- Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Insights From PREVENT IV.
- D-Dimer elevation and adverse outcomes.
- Impact of Intra-procedural Stent Thrombosis during Percutaneous Coronary Intervention: Insights from the CHAMPION PHOENIX Trial.
- Angiographic validation of the american college of cardiology foundation-the society of thoracic surgeons collaboration on the comparative effectiveness of revasculari...
- Angiographic Outcomes With Early Eptifibatide Therapy in Non-ST-Segment Elevation Acute Coronary Syndrome (from the EARLY ACS Trial).
- Clinical Implications and Correlates of Q Waves in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolysis: Observations from the CLARITY-TIMI 28 Tr...
- Endoscopic Harvesting Device Type and Outcomes in Patients Undergoing Coronary Artery Bypass Surgery.
- Is There a Need for "Triple Therapy"? Role of Anticoagulation with Dual Antiplatelet Therapy in Acute Coronary Syndromes (ATLAS Study & TRAP Study).
- Cessation of dual antiplatelet treatment and cardiac events after percutaneous Coronary intervention (PARIS): 2 year results from a prospective observational study.
- Comparison of the Efficacy and Safety of Two Rivaroxaban Doses in Acute Coronary Syndrome (from ATLAS ACS 2-TIMI 51).
- Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51.
- Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: The IntraCoronary Abciximab and Aspiration Thrombectomy in P...
- Relationship Between Myocardial Reperfusion, Infarct Size, and Mortality: The INFUSE-AMI (IntraCoronary Abciximab and Aspiration Thrombectomy in Patients With Large An...
- Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of in...
- Association of time to reperfusion with left ventricular function and Heart failure in patients with acute myocardial infarction treated with primary percutaneous coro...
- Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events.
- Stable isotope probing and Raman spectroscopy for monitoring carbon flow in a food chain and revealing metabolic pathway.
- Does Serum Bilirubin Level on Admission Predict TIMI Flow Grade and In-Hospital MACE in Patients With STEMI Undergoing Primary PCI.
- Phase II Safety and Clinical Comparison With Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging for Detection of Coronary Artery Disease: Flurpiri...
- Is thrombosis a contributor to Heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges.
- Prevalence, Consequences, and Implications for Clinical Trials of Unrecognized Myocardial Infarction.
- Urinary albumin concentration and long-term cardiovascular risk in Acute coronary syndrome patients: a PROVE IT-TIMI 22 substudy.
- The determinants of side branch compromise after main vessel stenting in Coronary bifurcation lesions.
- Optimal selection of STEMI treatment strategies in the current era: benefit of transferring STEMI patients for PCI compared with administration of onsite fibrinolytic ...
- Atherosclerotic risk factors and their association with hospital mortality among patients with first Myocardial infarction (from the National Registry of Myocardial In...
- Association Between Angiographic Complications and Clinical Outcomes Among Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An EARL...
- Edifoligide and long-term outcomes after Coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results.
- Significance of False Negative Electrocardiograms in Preparticipation Screening of Athletes for Hypertrophic Cardiomyopathy.
- Time-related impact of distal embolisation on Myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: in...
- Admission hyperglycemia and Acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics.
- Age, treatment, and outcomes in high-risk non-ST-segment elevation Acute coronary syndrome patients: Insights from the EARLY ACS trial.
- Impact of preprocedural TIMI flow on Myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation Myocardial infarction treated by pri...
- A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidog...
- The association of serum uric acid levels on Coronary flow in patients with STEMI undergoing primary PCI.
- Prior polyvascular disease: risk factor for adverse ischaemic outcomes in Acute coronary syndromes.
- Seasonal variation in lipids in patients following Acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorv...
- Antiplatelet therapy: anti-ischemic benefits versus bleeding risk.
- Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation Myocardial infarction en...
Schools
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Brigham and Womens Hospital Harvard
Beth Israel Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- Fellow (FACC)
Education
-
Beth Israel Deaconess Medical Center -
Brigham and Women's Hospital -
University of Chicago Pritzker School of Medicine
Hospital
-
Beth Israel Deaconess Medical Center -
Brigham and Women's Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1124053277 |
| Last Name Of The Provider | GIBSON |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
|
Dr. Robert W. Yeh, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Rajeev Malhotra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason G. Homsy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott D. Solomon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert M. Gallagher, MD |
|
|
Dr. Kerunne Ketlogetswe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter M. Kang, MD |
|
|
Dr. Chang-Seng Liang, MD |
|
|
Dr. Gary J. Balady, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samy Selim, MD
This Doctor is OpenDoctor Recommended.
|